Co-Diagnostics, Inc. (CODX)
| Previous close | 1.2300 |
| Open | 1.1700 |
| Bid | 0.8352 x 200 |
| Ask | 1.3300 x 200 |
| Day's range | 1.0300 - 1.1900 |
| 52-week range | 0.9750 - 1.8900 |
| Volume | |
| Avg. volume | 57,772 |
| Market cap | 34.698M |
| Beta (5Y monthly) | -0.65 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.2000 |
| Earnings date | 08 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 2.50 |
Insider MonkeyCo-Diagnostics, Inc. (NASDAQ:CODX) Q1 2024 Earnings Call Transcript
Co-Diagnostics, Inc. (NASDAQ:CODX) Q1 2024 Earnings Call Transcript May 9, 2024 Co-Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.31204 EPS, expectations were $-0.21. CODX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the […]
PR NewswireCo-Diagnostics, Inc. Reports First Quarter 2024 Financial Results
Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx," or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter ended March 31, 2024.
- PR Newswire
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast
Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter 2024 financial results on Thursday, May 9, 2024, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts and institutional investors. Management on the call will include Dwight Egan, Chief Exec
